NFE2L2 and asthma: The therapeutic potential of Nrf2 activators in asthma is further supported by the results of studies indicating that Nrf2 activation can suppress allergic lung inflammation by modulating the type 2 innate lymphoid cell response, which is crucial in the allergic immune response [107].